Ascend Wellness Holdings (AAWH) Retained Earnings (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Retained Earnings of $471.2 million for Q1 2026, little changed year-over-year from $471.3 million in Q1 2025, and little changed quarter-over-quarter from $470.9 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Retained Earnings (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Retained Earnings history runs 7 years deep, the most recent figure standing at $471.2 million for Q1 2026.
- In Q1 2026, Retained Earnings changed 0.01% year-over-year to $471.2 million; the TTM figure through Mar 2026 stood at $471.2 million (changed 0.01% YoY), while the FY2025 annual figure was $470.9 million, changed 0.05% from the prior year.
- Retained Earnings for Q1 2026 stood at $471.2 million, roughly flat from $470.9 million in the prior quarter.
- The five-year high for Retained Earnings was $471.4 million in Q3 2025, with the low at -$383.6 million in Q3 2024.
- The 5-year median for Retained Earnings is $450.5 million (2023), against an average of $147.1 million.
- The sharpest annual moves came in 2022 and 2024: Retained Earnings jumped 432.62% in 2022, then tumbled 178.86% in 2024.
- Ascend Wellness Holdings' Retained Earnings stood at -$267.1 million in 2022, then soared by 271.45% to $458.0 million in 2023, then rose by 2.86% to $471.1 million in 2024, then declined by 0.05% to $470.9 million in 2025, then advanced by 0.07% to $471.2 million in 2026.
- Business Quant data shows AAWH's Retained Earnings at $471.2 million in Q1 2026, $470.9 million in Q4 2025, and $471.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 3.75 Bn |
| 10 | Ascend Wellness Holdings | 98.46 Mn | 31.46 Mn | 45.49 Mn | -557.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -557.85 Mn |
| Mar 31, 2026 | 471.25 Mn |
| Dec 31, 2025 | 470.91 Mn |
| Sep 30, 2025 | 471.40 Mn |
| Jun 30, 2025 | 471.15 Mn |
| Mar 31, 2025 | 471.29 Mn |
| Dec 31, 2024 | 471.13 Mn |
| Sep 30, 2024 | -383.57 Mn |
| Jun 30, 2024 | -355.31 Mn |
| Mar 31, 2024 | 468.09 Mn |
| Dec 31, 2023 | 458.03 Mn |
| Sep 30, 2023 | -296.02 Mn |
| Jun 30, 2023 | 450.53 Mn |
| Mar 31, 2023 | -285.62 Mn |
| Dec 31, 2022 | -267.15 Mn |
| Sep 30, 2022 | -252.10 Mn |
| Jun 30, 2022 | -235.24 Mn |
| Mar 31, 2022 | 371.92 Mn |
| Dec 31, 2021 | 362.56 Mn |
| Sep 30, 2021 | -169.74 Mn |